» Articles » PMID: 21497384

Differentiation of Metastatic from Non-metastatic Lymph Nodes in Patients with Uterine Cervical Cancer Using Diffusion-weighted Imaging

Overview
Journal Gynecol Oncol
Date 2011 Apr 19
PMID 21497384
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aims to determine the diagnostic value of diffusion-weighted imaging (DWI) in the differentiation of metastatic lymph nodes from non-metastatic lymph nodes in uterine cervical cancer.

Methods: In 42 patients who underwent lymph node dissection for uterine cervical cancer, conventional MRI and DWI examinations were performed before surgery. Of the 1109 total dissected pelvic lymph nodes, 188 enlarged nodes with a short-axis diameter of 5mm or greater were included for further analysis. Each of the size-based criteria (i.e., short-axis diameter and long-axis diameter) and ADC-based criteria (i.e., mean ADC, minimum ADC, mean rADC (relative ADC) and minimum rADC) were compared between metastatic lymph nodes and non-metastatic lymph nodes.

Results: There were statistically significant differences between metastatic and non-metastatic lymph nodes in the short-axis diameter, long-axis diameter, mean ADC, minimum ADC, mean rADC and minimum rADC (P < 0.001). The Az of the minimum ADC (0.990) was greater than that of the other ADC-based criteria (0.974, 0.939, 0.976 for mean ADC, mean rADC and minimum rADC, respectively) and all size-based criteria (0.878 for short-axis diameter and 0.858 for long-axis diameter) (P < 0.05). Using the minimum ADC criteria (≤ 0.881 × 10⁻³ mm²/s), the sensitivity and specificity for differentiating metastatic from non-metastatic lymph nodes were 95.7% and 96.5%, respectively.

Conclusions: DWI is feasible for differentiating metastatic from non-metastatic pelvic lymph nodes in patients with uterine cervical cancer and minimum ADC could be served as a representative marker.

Citing Articles

Clinical Outcomes Between Completion and Abandonment of Radical Hysterectomy in Early-Stage Cervical Cancer Patients with Lymph Nodal Involvement Identified During Surgery: A Systematic Review and Meta-Analysis.

Chen H, Chen Y, Zheng A, Tan X, Han L Ann Surg Oncol. 2024; 31(13):8954-8960.

PMID: 39373932 DOI: 10.1245/s10434-024-16326-1.


Combining multimodal diffusion-weighted imaging and morphological parameters for detecting lymph node metastasis in cervical cancer.

Zhong S, Ai C, Ding Y, Tan J, Jin Y, Wang H Abdom Radiol (NY). 2024; 49(12):4574-4583.

PMID: 38990301 DOI: 10.1007/s00261-024-04494-3.


Outcome prediction of SSTR-RADS-3A and SSTR-RADS-3B lesions in patients with neuroendocrine tumors based on Ga-DOTATATE PET/MR.

Gao J, Zhou J, Liu C, Pan Y, Lin X, Zhang Y J Cancer Res Clin Oncol. 2024; 150(5):272.

PMID: 38795250 PMC: 11127844. DOI: 10.1007/s00432-024-05776-5.


A prognostic model using FIGO 2018 staging and MRI-derived tumor volume to predict long-term outcomes in patients with uterine cervical squamous cell carcinoma who received definitive radiotherapy.

Zang L, Chen Q, Lin A, Chen J, Zhang X, Fang Y World J Surg Oncol. 2023; 21(1):210.

PMID: 37475053 PMC: 10360277. DOI: 10.1186/s12957-023-03116-4.


The role of apparent diffusion coefficient (ADC) in the evaluation of lymph node status in patients with locally advanced cervical cancer: our experience and a review.

Gui B, Russo L, Minordi L, Micco M, Persiani S, Avesani G Pol J Radiol. 2022; 87:e438-e447.

PMID: 36091653 PMC: 9453471. DOI: 10.5114/pjr.2022.118914.